A novel designed single domain antibody on 3-D structure of ricin A chain remarkably blocked ricin-induced cytotoxicity

Molecular Immunology

Volumn 43, Issue 11, 2006, Pages 1912-1919

  Shuntao, Wang ^a,b   Jiannan, Feng ^a   Jianwei, Guo ^a   Leiming, Guo ^a   Yan, Li ^a   Yingxun, Sun ^a   Weisong, Qin ^a   Meiru, Hu ^a   Gencheng, Han ^a   Beifen, Shen ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b Department of Tumor Surgery   (China)

Author keywords

Molecular modeling; Ricin A chain; Ricin induced cytotoxicity; Single domain antibody

Indexed keywords

RECOMBINANT ANTIBODY; RIBOSOME RNA; RICIN A; RICIN ANTIBODY;

ANTIBODY STRUCTURE; ARTICLE; COMPUTER SYSTEM; CONTROLLED STUDY; CRYSTAL STRUCTURE; CYTOTOXICITY; DRUG INHIBITION; ESCHERICHIA COLI; HUMAN; HUMAN CELL; MOLECULAR MODEL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN STRUCTURE;

ANTIBODIES; BINDING SITES, ANTIBODY; BINDING, COMPETITIVE; CLONING, MOLECULAR; CYTOTOXICITY, IMMUNOLOGIC; DRUG DESIGN; GENE EXPRESSION; HUMANS; MODELS, MOLECULAR; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT FUSION PROTEINS; RICIN;

ESCHERICHIA COLI;

EID: 33644938073     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2005.10.012     Document Type: Article

References (42)

1. G.M. Arbabi, A. Desmyter, L. Wyns, R. Hamers, and S. Muyldermans Selection and identification of single domain antibody fragments from camel heavy-chain antibodies FEBS Lett. 414 1997 521 526
2. R. Baluna, J. Rizo, B.E. Gordon, V. Ghetie, and E.S. Vitetta Evidence for a structural motif in toxins and interleukin-2 that may be responsible for binding to endothelial cells and initiating vascular leak syndrome Proc. Natl. Acad. Sci. U.S.A. 96 1999 3957 3962
3. N. Ban, P. Nissen, J. Hansen, M. Capel, P.B. Moore, and T.A. Steitz Placement of protein and RNA structures into a 5 A-resolution map of the 50S ribosomal subunit Nature 400 1999 841 847
4. L) intracellular antibody specific for the amino terminus of huntingtin via yeast surface display J. Mol. Biol. 342 2004 901 912
5. B. Corthesy, M. Kaufmann, A. Phalipon, M. Peitschi, M.R. Neutra, and J. Kraehenbuhl A pathogen-specific epitope inserted into recombinant secretory immunoglobulin A is immunogenic by the oral route J. Biol. Chem. 271 1996 33670 33677
6. J. Daies, and L. Riechmann Antibody VH domains as small recognition units Biotechnology 13 1995 475 479
7. P.J. Day, S.R. Ernst, A.E. Frankel, A.F. Monzingo, J.M. Pascal, M.C. Molina-Svinth, and J.D. Robertus Structure and activity of an active site substitution of ricin A chain Biochemistry 35 1996 11098 11103
8. A. Desmyte, S. Spinelli, F. Payan, M. Lauwereys, L. Wyns, S. Muyldermans, and C. Cambillau Three camelid VHH domains in complex with porcine pancreatic-amylase J. Biol. Chem. 277 2002 23645 23650
9. A. Desmyter, T.R. Transue, M.A. Ghahroudi, M.H. Thi, F. Poortmans, R. Hamers, S. Muyldermans, and L. Wyns Crystal structure of a camel single-domain VH antibody fragment in complex with lysozyme Nat. Struct. Biol. 3 1996 803 811
10. T. Dottorini, C.K. Vaughan, M.A. Walsh, P. Losurdo, and M. Sollazzo Crystal structure of a human VH: requirements for maintaining a monomeric fragment Biochemistry 43 2004 622 628
11. M. Dumoulin, K. Conrath, A.V. Meirhaeghe, F. Meersman, K. Heremans, L.G.J. Frenken, S. Muyldermans, L. Wyns, and A. Matagne Single-domain antibody fragments with high conformational stability Protein Sci. 11 2002 500 515
12. M. Dumoulin, A.M. Last, A. Desmyter, K. Decanniere, D. Canet, G. Larsson, A. Spencer, D.B. Archer, J. Sasse, S. Muyldermans, L. Wyns, C. Redfield, A. Matagne, C.V. Robinson, and C.M.A. Dobson Camelid antibody fragment inhibits the formation of amyloid fibrils by human lysozyme Nature 424 2003 783 788
13. J. Feng, Y. Li, and B. Shen The design of antagonist peptide of hIL-6 based on the binding epitope of hIL-6 by computer-aided molecular modeling Peptides 25 2004 1123 1131
14. E.D. Genst, D. Areskoug, K. Decanniere, S. Muyldermans, and K. Andersson Kinetic and affinity predictions of a protein-protein interaction using multivariate experimental design J. Biol. Chem. 277 2002 29897 29907
15. C. Hamers-Casterman, T. Atarhouch, S. Muyldermans, G. Robinson, C. Hamers, E.B. Songa, N. Bendahman, and R. Hamers Naturally occurring antibodies devoid of light chains Nature 363 1993 446 448
16. R.M. Horton, H.D. Hunt, S.N. Ho, J.K. Pullen, and L.R. Pease Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension Gene 77 1989 61 68
17. H. Jin, J. Sepulveda, and O.R. Burrone Selection and characterisation of binders based on homodimerisation of immunoglobulin V(H) domains FEBS Lett. 554 2003 323 329
18. S.A. Jobling, C. Jarman, M.M. The, N. Holmberg, C. Blake, and M.E. Verhoeyen Immunomodulation of enzyme function in plants by single-domain antibody fragments Nat. Biotechnol. 21 2003 77 80
19. R.J. Kreitman Immunotoxins in cancer therapy Curr. Opin. Immunol. 11 1999 570 578
20. J.M. Lord, N.A. Jolliffe, C.J. Marsden, C.S. Pateman, D.C. Smith, R.A. Spooner, P.D. Watson, and L.M. Roberts Ricin: mechanisms of cytotoxicity Toxicol. Rev. 22 2003 53 64
21. J.M. Lord, L.M. Roberts, and J.D. Robertus Ricin: structure, mode of action, and some current applications FASEB J. 8 1994 201 208
22. C.J. Marsden, V. Fulop, P.J. Day, and J.M. Lord The effect of mutations surrounding and within the active site on the catalytic activity of ricin A chain Eur. J. Biochem. 271 2004 153 162
23. D.J. Miller, K. Raikumar, H. Shen, J. Suh, S.M. Kerwin, and J.D. Robertus Structure-based design and characterization of novel platforms for ricin and shiga toxin inhibition J. Med. Chem. 45 2002 90 98
24. D. Mlsna, A.F. Monzingo, B.J. Katzin, S. Ernst, and J.D. Robertus Structure of recombinant ricin A chain at 2.3 A Protein Sci. 2 1993 429 435
25. S.J. Muyldermans Single domain camel antibodies: current status Biotechnology 74 2001 277 302
26. S. Muyldermans, C. Cambillau, and L. Wyns Recognition of antigens by single-domain antibody fragments: the superfluous luxury of paired domains Trends Biochem. Sci. 26 2001 230 235
27. S.D. Nuttal, R.A. Irving, and P.J. Hudson Immunoglobulin VH domains and beyond: design and selection of single-domain binding and targeting reagents Curr. Pharm. Biotechnol. 1 2000 253 263
28. W. Qin, J. Feng, W. Zhang, Y. Li, and B. Shen A novel TNFa antagonizing peptide-Fc fusion protein designed based on CDRs of TNFa neutralizing monoclonal antibody Biochem. Biophys. Res. Commun. 322 2004 1024 1028
29. G.J.A. Rainey, and J.A.T. Young Antitoxins: novel strategies to target agents of bioterrorism Nat. Rev. Microbiol. 2 2004 721 726
30. D. Saerens, J. Kinne, E. Bosnians, U. Wernery, S. Muyldermans, and K. Conrath Single domain antibodies derived from dromedary lymph nodeand peripheral blood lymphocytes sensing conformational variants of prostate-specific antigen J. Biol. Chem. 279 2004 51965 51972
31. J. Sambrook, and W.R. David Molecular Cloning: A Laboratory Manual third ed. 2001 Cold Spring Harbor Laboratory Press Plainview, NY
32. F.A. Silva, M. Santa-Marta, A. Freitas-Vieira, P. Mascarenhas, I. Barahona, J. Moniz-Pereira, D. Gabuzda, and J. Goncalves Camelized rabbit-derived VH single-domain intrabodies against Vif strongly neutralize HIV-1 infectivity J. Mol. Biol. 340 2004 525 542
33. R.L. Stanfield, H. Dooley, M.F. Flajnik, and I.A. Wilson Crystal structure of a shark single-domain antibody V region in complex with lysozyme Science 305 2004 1770 1773
34. W. Vranken, D. Tolkatchev, P. Xu, J. Tanha, Z. Chen, S. Narang, and F. Ni Solution structure of a llama single-domain antibody with hydrophobic residues typical of the VH/VL interface Biochemistry 41 2002 8570 8579
35. E.S. Ward, D. Gussow, A.D. Griffiths, P.T. Jones, and G. Winter Binding activities of a repertoire of single immunoglobulin variable domains secreted from Escherichia coli Nature 341 1989 544 546
36. S.A. Weston, A.D. Tucker, D.R. Thatcher, D.J. Derbyshire, and R.A. Pauptit X-ray structure of recombinant ricin A-chain at 1.8 A resolution J. Mol. Biol. 244 1994 410 422
37. S. Xiong, M. Gerloni, and M. Zanetti Engineering vaccines with heterologous B and T cell epitopes using immunoglobulin genes Nat. Biotechnol. 15 1997 882 886
38. H. Zaghouani, Y. Kuzo, H. Kuzo, N. Mann, C. Daian, and C. Bona Engineered immunoglobulin molecules as vehicles for T cell epitopes Int. Rev. Immunol. 10 1993 265 278
39. H. Zaghouani, R. Steinman, R. Nonacs, H. Shah, W. Gerhard, and C. Bona Presentation of a viral T cell epitope expressed in the CDR3 region of a self immunoglobulin molecule Science 259 1993 224 227
40. M. Zanetti Antigenized antibodies Nature 355 1992 476 477
41. M. Zanetti, G. Filaci, R.H. Lee, P. del Guercio, F. Rossi, R. Bacchetta, F. Stevenson, V. Barnaba, and R. Billetta Expression of conformationally constrained adhesion peptide in an antibody CDR loop and inhibition of natural killer cell cytotoxic activity by an antibody antigenized wilhthe RGD motif EMBO J. 12 1993 4375 4384
42. M. Zanetti, R. Rossi, P. Lanza, G. Filaci, R.H. Lee, and R. Billetta Theoretical and practical aspects of antigenized antibodies Immunol. Rev. 130 1992 125 145